Related by context. All words. (Click for frequent words.) 72 lymphomas 68 leukaemias 66 non Hodgkin lymphomas 66 cell lymphomas 66 chronic lymphocytic leukemia CLL 65 cancers 64 malignancies 63 chronic myeloid leukemia CML 63 glioblastoma 63 chronic myelogenous leukemia CML 63 acute myeloid leukemia AML 62 leukemia ALL 62 leukemia AML 62 myeloproliferative diseases 61 neuroendocrine tumors 61 Follicular lymphoma 61 medulloblastoma 61 cell malignancies 60 Chronic myeloid leukemia 60 essential thrombocythemia 60 myeloid 60 Acute lymphoblastic leukemia 60 pancreatic cancers 60 glioblastoma multiforme GBM 60 acute leukemias 60 medulloblastomas 59 Gleevec resistant 59 indolent NHL 59 histologies 59 hematologic malignancies 59 Non Hodgkin lymphoma 59 Chronic lymphocytic leukemia 59 cell acute lymphoblastic 59 myelofibrosis polycythemia vera 59 gastrointestinal stromal tumors 59 sarcomas 59 T#I mutant 59 non Hodgkin lymphoma 58 autoimmune diseases 58 neuroblastomas 58 osteosarcomas 58 childhood leukemias 58 follicular lymphoma 58 familial ALS 58 neuroendocrine cancers 58 Glioblastoma 58 solid tumors 58 bladder cancers 58 SOD1 58 K ras mutations 58 myeloid cells 57 myeloid leukemia 57 myelodysplastic syndrome MDS 57 lymphoproliferative disorders 57 BRAF gene 57 epithelial tumors 57 myeloproliferative neoplasms 57 imatinib Gleevec 57 hematologic cancers 57 glioblastomas 57 hematologic disorders 57 thyroid cancers 57 grade gliomas 56 lymphoblastic leukemia 56 autoinflammatory diseases 56 B CLL 56 acute lymphoid leukemia 56 herpes viruses 56 medullary thyroid cancer 56 malignant tumors 56 acute myeloid leukemia 56 imatinib resistance 56 Gliomas 56 basal cell nevus syndrome 56 epithelial cancers 56 BCR ABL 56 Leukemias 56 B lymphocytes 56 chromosomal translocations 56 Acute myeloid leukemia 56 V#F mutation 56 GISTs 56 hematological cancers 56 glioblastoma tumors 56 leukemias lymphomas 56 hematological malignancies 56 astrocytomas 56 leukemia CML 56 cell lymphoma CTCL 56 carcinoid 56 chronic myelogenous leukemia 56 heavily pretreated 56 leukemia CLL 56 lymphoma subtypes 56 acute myelogenous leukemia AML 56 Synovial sarcoma 56 MALT lymphoma 56 chronic lymphocytic leukemia 55 Acute myeloid leukemia AML 55 Glioblastomas 55 CLL 55 acute leukemia 55 anemias 55 carcinoid tumors 55 protein kinases 55 lupus nephritis 55 squamous cell lung cancer 55 serous ovarian cancer 55 pancreatic adenocarcinoma 55 hemolytic anemia 55 MYCN amplification 55 myeloproliferative disorders 55 Basal cell 55 acute lymphoblastic leukemia 55 Pancreatic neuroendocrine tumors 55 prostate pancreatic 55 lung cancers 55 nilotinib 55 pediatric acute lymphoblastic 55 adenocarcinomas 55 nonsmall cell lung cancer 55 non metastatic osteosarcoma 55 neuroblastoma 55 Cholangiocarcinoma 55 DLBCL 55 mitochondrial disorders 55 tumors 55 oncoproteins 55 dermatofibrosarcoma protuberans 55 HCV infections 55 standard chemotherapy regimens 55 MDM2 55 Hedgehog signaling pathway 55 systemic lupus erythematosus 55 FLT3 55 T#I [002] 55 renal cell carcinoma 54 hypereosinophilic syndrome 54 leukemia 54 myelodysplasia 54 lymphoma 54 myeloma cells 54 tumor suppressor genes 54 myeloproliferative 54 systemic lupus erythematosus SLE 54 smoldering myeloma 54 gastrointestinal stromal tumor 54 dasatinib 54 squamous cell carcinoma SCC 54 lymphocytic leukemia 54 Cutaneous T 54 renal cell carcinomas 54 JMML 54 Non Hodgkins lymphoma 54 commonly mutated genes 54 Philadelphia Chromosome Positive 54 breast carcinomas 54 dyskeratosis congenita 54 ovarian cancers 54 autoimmune disease 54 GBMs 54 Th# cells 54 Chronic Lymphocytic Leukemia CLL 54 neurodegenerative disorder 54 gliomas 54 colon cancers 54 chronic myeloid 54 acute promyelocytic leukemia 54 mycosis fungoides 54 Epratuzumab 54 myelodysplastic syndromes 54 malignant gliomas 54 androgen receptor AR 54 leukemic stem cells 54 NSCLC 54 pan HDAC inhibitor 54 tyrosine kinase inhibitors 54 HCV infection 54 hematological diseases 54 Lymphomas 54 EZH2 54 ovarian tumors 54 tumor suppressors 54 squamous cell carcinomas 54 sporadic ALS 54 Treg cell 54 gastrointestinal cancers 54 B lymphocyte 54 Acute Lymphoblastic Leukemia 54 lymphoid 54 acute lymphoblastic 54 pheochromocytoma 54 metastatic cancer 54 polycythemia vera 54 prostate cancers 54 respiratory viral infections 53 squamous cell 53 Burkitt lymphoma 53 Myelofibrosis 53 trans retinoic acid 53 CD# mAb 53 Epstein Barr virus EBV 53 carcinoid cancer 53 Acute lymphocytic leukemia 53 multiple myeloma 53 chromosomal translocation 53 metastatic melanoma 53 multiple myeloma MM 53 EGFRvIII 53 GBM tumors 53 Hodgkin lymphoma HL 53 CMV infection 53 metastatic cancers 53 PCNSL 53 Wnt signaling pathway 53 soft tissue sarcomas 53 Carcinoid tumors 53 NF kB pathway 53 myotonic dystrophy 53 PTEN mutations 53 tuberous sclerosis complex 53 lymphoma CTCL 53 immunodeficiency 53 ependymomas 53 basal cell carcinomas 53 Glioblastoma multiforme GBM 53 hypoxia inducible factor 53 lymphoid malignancies 53 PTLD 53 neuroblastoma cells 53 HPVs 53 Glioblastoma Multiforme 53 recurrent glioblastoma multiforme GBM 53 Malignant melanoma 53 anaplastic 53 Anaplastic 53 motor neuron degeneration 53 Non Hodgkin Lymphoma 53 ependymoma 53 chromosomal rearrangement 53 JAK mutations 53 Non Hodgkin 53 Toxicities 53 lymphoid organs 53 lymphoid tissue 53 lysosomal storage disease 53 mesotheliomas 53 Foxp3 53 brain tumor glioblastoma multiforme 53 ADPKD 53 IDH2 53 myelogenous leukemia 53 cutaneous T 53 leukemic 53 myelofibrosis 53 Hashimoto thyroiditis 53 Diffuse Large B 53 CLL SLL 53 cell lymphoma 53 dasatinib Sprycel 53 TTR amyloidosis 53 indolent lymphoma 53 metastatic colon cancer 53 follicular lymphoma FL 53 myelomas 53 gastric cancers 53 mitochondrial dysfunction 53 colorectal cancer CRC 53 Waldenstrom macroglobulinemia 53 Acute myelogenous leukemia 53 Fludarabine 53 Glioblastoma multiforme 53 malignant transformation 53 basal cell carcinoma BCC 53 mutations 53 TREANDA 53 gastrointestinal stromal tumors GISTs 53 molecular abnormalities 53 Osteosarcoma 53 CD8 + 52 Novartis Gleevec 52 beta thalassemia 52 fatal neurodegenerative 52 Hodgkin lymphoma NHL 52 oncogenes 52 tyrosine kinases 52 NFκB 52 alveolar rhabdomyosarcoma 52 mutated KRAS gene 52 JAK2 52 imatinib resistant 52 Hedgehog pathway 52 myeloproliferative disorder 52 atypical hemolytic uremic syndrome 52 EGFR mutations 52 imatinib Gleevec ® 52 vWF 52 c MET 52 Chronic lymphocytic leukemia CLL 52 GSTP1 52 T#I mutation 52 Inflammatory breast cancer 52 Prion diseases 52 acute myelogenous leukemia 52 gastric carcinoma 52 carcinomas 52 idiopathic thrombocytopenic purpura ITP 52 relapsed refractory 52 Neuroblastoma 52 pancreatic neuroendocrine 52 juvenile myelomonocytic leukemia 52 TTR gene 52 Akt1 52 lung carcinomas 52 Inflammatory bowel diseases 52 Ph + acute lymphoblastic 52 relapsed leukemia 52 nonmelanoma skin cancers 52 endometrial cancers 52 NKT cells 52 breast ovarian 52 metastatic kidney 52 CYT# potent vascular disrupting 52 FSGS 52 chronic myeloid leukemia 52 HER2 positive breast cancer 52 synovial sarcoma 52 VZV 52 hypophosphatasia 52 Medullary thyroid cancer 52 cutaneous T cell 52 castration resistant 52 recurrent glioblastoma 52 hepatocellular carcinoma HCC 52 narcolepsy cataplexy 52 Chronic myeloid leukemia CML 52 Metastatic breast cancer 52 hedgehog pathway 52 superantigens 52 melanoma 52 malignant pleural mesothelioma 52 Multiple myeloma 52 lymphocytic 52 HLA B# 52 Staphylococcus aureus infections 52 autoinflammatory 52 systemic amyloidosis 52 medulloblastoma tumors 52 ovarian lung 52 angiosarcoma 52 lysosomal storage diseases 52 JAK2 enzyme 52 GNAQ 52 refractory CML 52 Myelodysplastic syndromes MDS 52 Malignant mesothelioma 52 effector T 52 Ribavirin causes 52 gastrointestinal stromal tumors GIST 52 costimulatory 52 Glioma 52 ALK mutations 52 MGUS 52 ccRCC 52 FGFR2 52 anaplastic lymphoma kinase 52 angiogenesis inhibition 52 GIST tumors 52 Pleural mesothelioma 52 myelofibrosis MF 52 homozygous FH 52 lymphocytes 52 receptor tyrosine kinase inhibitor 52 Acute Myeloid Leukemia 52 Aurora kinase 52 bevacizumab Avastin ® 52 JAK3 52 fungoides 52 S. aureus infections 52 haematological malignancies 52 lymphoid tumors 52 refractory chronic myeloid 52 breast cancers 52 Metastatic 52 Sezary syndrome 52 interleukins 52 thymoma 52 post transplant lymphoproliferative 52 leukemic cells 52 proliferative disorders 52 Rituxan rituximab 52 leukemia APL 52 mediated autoimmune diseases 52 pneumococcal strains 52 PI3K Akt 52 epigenetic mechanisms 52 hypercalcemia 52 chronic eosinophilic leukemia 52 interferon pathway 51 Acute Myelogenous Leukemia AML 51 H. pylori infection 51 hepatocellular carcinomas 51 EGFr 51 histiocytosis 51 proto oncogene 51 sarcoma 51 seropositive patients 51 fatal neurodegenerative disorder 51 acute lymphocytic leukemia 51 pancreatic lung 51 pilocytic astrocytomas 51 oncogenesis 51 skin cancers 51 Enzastaurin 51 EBV infection 51 Janus kinase 51 PC# cells 51 papillary renal cell carcinoma 51 microglial cells 51 Omacetaxine 51 relapsing remitting 51 polycythemia vera PV 51 hypermethylation 51 seminomas 51 IL 1ß 51 malignancy 51 gastric cancer 51 MAP kinases 51 Merkel cell carcinoma 51 hematologic 51 AML acute myeloid 51 KRAS mutant 51 malignant melanomas 51 oncogenic 51 Zolinza 51 lung prostate 51 immunodeficiencies 51 cardiac hypertrophy 51 tumor metastases 51 telomere dysfunction 51 Chronic Myelogenous Leukemia CML 51 interferon IFN 51 erythropoiesis 51 metastatic colorectal cancer 51 squamous cell cancer 51 tumor antigen 51 papillary 51 VIPR2 51 adrenocortical cancer 51 Wilms tumor 51 FOXP3 51 Alemtuzumab 51 mastocytosis 51 acute GvHD 51 Myelodysplastic syndromes 51 parainfluenza virus 51 TLR9 agonists 51 HER2 overexpression 51 Ilaris 51 Renal cell carcinoma 51 LRP5 51 colorectal cancers 51 TACI Ig 51 Peutz Jeghers syndrome 51 Epstein Barr virus 51 diabetic nephropathy 51 Notch1 51 autoimmune disorders 51 Systemic lupus erythematosus SLE 51 tumor xenograft models 51 hepatorenal syndrome 51 FTLD 51 refractory anaplastic astrocytoma 51 associated lymphoid tissue 51 frontotemporal dementia 51 MPS IVA 51 malignant lymphomas 51 Th2 cytokines 51 Clostridium difficile infection 51 squamous 51 chemokine receptors 51 kidney urologic 51 nasopharyngeal cancer 51 BRCA deficient 51 progressive multifocal leukoencephalopathy PML 51 Acute Leukemia 51 HbF 51 colorectal lung 51 premalignant 51 NF kappa B 51 coagulation cascade 51 transgenic rats 51 Acoustic neuromas 51 metastatic lung cancer 51 huC# DM4 51 acute myeloid 51 lymphoid cells 51 cytotoxin 51 colorectal breast 51 prostate tumors 51 pancreatic endocrine 51 activating mutations 51 Aurora kinases 51 VEGF inhibitors 51 JNK pathway 51 small lymphocytic lymphoma 51 lung pancreatic 51 hepatitis C HCV 51 nasopharyngeal carcinoma 51 erlotinib Tarceva ® 51 Bcr Abl 51 acute promyelocytic leukemia APL 51 MAPK pathway 51 bowel cancers 51 familial pancreatic cancer 51 aplastic anemia 51 pDCs 51 pancreatic tumors 51 sarcomatoid 51 MELAS 51 Genentech Rituxan 51 targeting CD# 51 lymphatic tissue 51 primary immunodeficiency 51 CD8 T cells 51 Chronic Lymphocytic Leukemia 51 cisplatin resistant 51 demyelinating disease 51 lung tumors 51 EGFR inhibitors 51 A3 adenosine receptor 51 mTOR mammalian target 51 Autoimmune disorders 51 systemic scleroderma 51 Sjögren syndrome 51 Niemann Pick disease 51 Dasatinib 51 chronic granulomatous disease 51 SOD1 gene 51 ara C 51 CD# antigen 51 metastatic malignant melanoma 51 castrate resistant 51 Alzheimer Disease AD 51 Evoltra ® 51 Kit CD# positive 51 homozygous familial hypercholesterolemia 51 Th2 cells 51 azacytidine 51 neoplasms 51 Ceflatonin 51 progressive neurodegenerative disorder 51 MDSCs 51 CDH1 51 endocrine tumors 51 spermidine 51 chronic viral infections 51 CD# [002] 51 lymphocyte activation 51 abnormal lymphocytes 51 receptor subtype 51 Autoimmune diseases 51 beta adrenergic receptors 51 eosinophils 51 glioblastoma multiforme 51 autoimmunity 51 Medulloblastoma 51 XMRV infection 50 Acute Myeloid Leukemia AML 50 Acute Myelogenous Leukemia 50 AAV2 50 allergic diseases 50 miRNA genes 50 pituitary adenomas 50 PDGFRA 50 fatal neuromuscular disorder 50 pDC 50 Basal cell carcinoma 50 CD8 T 50 hepatoma 50 KRAS oncogene 50 hamartomas 50 malignant melanoma 50 ovarian breast 50 familial adenomatous polyposis 50 cyclin dependent kinases 50 #beta HSD1 50 WT1 50 metastatic neuroendocrine tumors 50 non Hodgkin Lymphoma 50 cyclin dependent kinases CDKs 50 colony stimulating factors 50 lung cancer NSCLC 50 PARP inhibitors 50 DHFR 50 apoptotic pathway 50 neuro degenerative disease 50 breast pancreatic 50 inflammatory bowel diseases 50 beta1 integrin 50 xenograft models 50 pediatric malignancies 50 hereditary predisposition 50 skeletal metastases 50 NOTCH1 50 HER2 positive cancers 50 lupus 50 lung fibrosis 50 Squamous cell 50 Cyclin D1 50 oligodendrogliomas 50 cilengitide 50 RANKL 50 spinal muscular atrophy SMA 50 idiopathic thrombocytopenic purpura 50 anti angiogenic therapy 50 Li Fraumeni Syndrome 50 Smad3 50 differentiated thyroid 50 inflammatory diseases 50 lymphomas leukemias 50 vWD 50 rhabdomyosarcoma 50 sCJD 50 activin 50 neurite outgrowth 50 Neuvenge 50 AAT deficiency 50 Chronic Myeloid Leukaemia 50 mammary tumors 50 recurrent NSCLC 50 muscular dystrophies 50 Sudhir Agrawal D.Phil 50 gene rearrangements 50 endostatin 50 decitabine 50 activating mutation 50 pancreatic NET 50 cutaneous melanoma 50 inherited mutations 50 Campath alemtuzumab 50 varicella zoster virus 50 systemic mastocytosis 50 cediranib 50 AEG# 50 SJIA 50 relapsed ovarian cancer 50 CTLA 4 50 JAK inhibitors 50 astrocytoma 50 HBeAg negative 50 demyelinating diseases 50 TGF beta 50 spontaneous mutations 50 Meningiomas 50 Myelodysplastic syndrome 50 cancer 50 LHRH analogues 50 EGFR blockers 50 PARP inhibition 50 microRNA miR 50 tRNA synthetases 50 NKX#.# 50 prostate breast 50 cell carcinoma 50 CDK4 50 MEK inhibitors 50 essential thrombocythemia ET 50 chemoresistance 50 germline mutations 50 hepatocellular carcinoma 50 Ph + ALL 50 neurodegenerative disease 50 MAb 50 glioma cells 50 alefacept 50 cirrhosis liver failure 50 MLL AF9 50 Myelodysplastic Syndrome MDS 50 diffuse intrinsic pontine glioma 50 squamous cell cancers 50 histone deacetylase HDAC inhibitor 50 cytopenias 50 cytogenetic responses 50 systemic juvenile idiopathic 50 hepatocellular cancer 50 pancreatic colon 50 refractory acute myeloid 50 brain tumors 50 Cancers 50 subtype 50 hypomethylating agents 50 recurrent ovarian cancer 50 microdeletion 50 anticancer therapy 50 pneumococcal infection 50 alkylating agents 50 immune thrombocytopenic purpura 50 suppressor cells 50 IL 1β 50 IKZF1 50 neuropsychiatric diseases 50 Chronic Myeloid Leukemia 50 myeloproliferative neoplasms MPNs 50 Testicular cancer 50 tumor regressions 50 EoE 50 common hematologic malignancy 50 familial amyloidotic polyneuropathy FAP 50 renal carcinoma 50 immune modulators 50 TMEM#B 50 humanized monoclonal antibody 50 brain metastases 50 leukemia myeloma 50 YONDELIS 50 secondary hyperparathyroidism 50 Hurler syndrome 50 tubulin inhibitor 50 pharmacological chaperone compounds 50 gynecological cancers 50 thalidomide Thalomid 50 hA# 50 galiximab 50 signal transduction pathways 50 systemic lupus erythematosus lupus 50 Maroteaux Lamy syndrome 50 HSV1 50 Malignant gliomas 50 mTOR inhibitors 50 neurofibromas 50 depsipeptide 50 oncoprotein 50 huN# DM1 50 Vidaza ® 50 ADAM# 50 hematopoietic malignancies 50 HER2 positive 50 chronic HBV 50 inflammatory bowel disease 50 metastatic uveal melanoma 50 salinomycin 50 primary biliary cirrhosis 50 anti leukemic 50 BMPR2 50 ductal breast cancer 50 bone metastasis 50 demonstrated antitumor activity 50 metastatic colorectal 50 neoplasias 50 bendamustine 50 NF1 50 Kufs disease 50 Kaposi sarcoma 50 IGF 1R 50 myelodysplastic syndromes MDS 50 Six3 50 ovarian pancreatic 50 motor neuron diseases 50 opportunistic pathogens 50 imatinib 50 lymphoblasts 50 testicular cancers 50 fungal meningitis 50 trans retinoic acid ATRA 50 enzyme deficiency 50 Melanoma 50 idiopathic PAH 50 Hepatocellular carcinoma 50 aHUS 50 BCR ABL inhibitors 50 proteasome inhibitor 50 cell lymphoma ALCL 50 mutated genes 50 aneuploid cells 50 pancreatic neuroendocrine tumors 50 Glioblastoma Multiforme GBM 50 cyclin E 50 Cell Lymphoma 50 Tay Sachs thalassemia 50 relapsed SCLC 50 autosomal recessive 50 gene mutations 50 imatinib therapy 50 MCyR 50 AAT Deficiency 50 necrotizing pneumonia 50 pemphigus vulgaris 50 AP# [003] 50 ON #.Na 50 IgA antibodies 50 seminoma 50 encephalitis swelling 50 tumor suppressor protein 50 FGFR1 50 glycolipids 50 chemo resistant 50 carbohydrate antigens 50 histologic subtypes 50 topotecan 50 HDACi 50 primitive neuroectodermal tumors 50 chromosome abnormality 50 AMN# [001] 50 pneumococcus 50 RKIP 50 Hodgkin lymphomas 50 metastatic lesions 50 liver metastases 50 NPM1 50 investigational therapies 50 carcinoma 50 relapsed acute myelogenous 50 GRN#L 49 refractory CTCL 49 alpha interferons 49 refractory chronic lymphocytic 49 Panzem 49 T Cell Lymphoma 49 GATA3 49 monogenic 49 Haptoglobin 49 prostate adenocarcinoma 49 PPAR γ 49 multiple sclerosis lupus 49 paragangliomas 49 panobinostat 49 severe hypersensitivity reactions 49 hyperoxaluria 49 lymphoblastic lymphoma 49 CLL cells 49 tumor regression 49 AA amyloidosis 49 Renal impairment 49 relapsed Acute Myeloid 49 malignant lymphoma 49 retinoblastoma 49 HGPS 49 interferon gamma 49 immunological diseases 49 proteasome inhibitors 49 adrenocortical carcinoma 49 epithelial tissues 49 pancreatic carcinoma 49 esophageal cancers 49 mCRC patients 49 neurodegenerative diseases 49 Ph + 49 neuropsychiatric disorder 49 androgen independent 49 indolent follicular non 49 Amrubicin 49 Xanafide 49 curable cancers 49 phase Ph + 49 Malignant Melanoma 49 candidemia 49 peritoneal carcinomatosis 49 breast tumors 49 Mantle Cell Lymphoma 49 pneumonias 49 Chronic Myelogenous Leukemia 49 molecularly targeted 49 Vidofludimus 49 calcitriol 49 decompensated liver disease 49 anti CD3 antibody 49 mutated KRAS 49 tyrosine kinase inhibitors TKIs 49 SSc 49 Endometrial cancer 49 neoplastic 49 c myc 49 Th2 49 Stomach cancer 49 non alcoholic steatohepatitis 49 varicella zoster virus VZV 49 HPV# 49 EGFR mutant 49 pathogenic mutations 49 Atopic dermatitis 49 CHOP chemotherapy 49 herpesviruses 49 STK# [002] 49 Raf MEK ERK 49 immunopathology 49 panitumumab Vectibix 49 genomic instability 49 progranulin 49 GSK3 49 poly ADP ribose polymerase 49 CD# + [001] 49 ovarian carcinoma 49 gastric carcinogenesis 49 leukaemic stem cells 49 colorectal carcinoma 49 HER2 positive metastatic breast 49 Novartis AG Gleevec 49 Acute Lymphoblastic Leukaemia 49 prostate ovarian 49 PI3K inhibitors 49 chronic hepatitis 49 protein tyrosine phosphatase 1B 49 pancreatic prostate 49 JAK2 gene 49 cetuximab Erbitux 49 hyperphosphorylation 49 metastatic bladder 49 autoimmune hemolytic anemia 49 cancer mCRC 49 investigational monoclonal antibody 49 Marqibo 49 IMGN# 49 HCV protease 49 autoimmune 49 MabThera Rituxan 49 CD# CEA 49 Th1 cells 49 Hepatocellular Carcinoma HCC 49 holoprosencephaly 49 hematological malignancy 49 orthotopic model 49 antiangiogenesis therapies 49 gastrointestinal stromal tumor GIST 49 STAT3 49 spinal muscle atrophy 49 mammary cells 49 cell signaling pathway 49 sortilin 49 chronic HBV infection 49 autoantibodies 49 CTCL 49 Nilotinib 49 childhood acute lymphoblastic 49 GSTT1 49 pheochromocytomas 49 recessive dystrophic epidermolysis bullosa 49 HBeAg positive 49 Bloodstream infections 49 prostate cancer PCa 49 AML MDS 49 immune mediated 49 adenocarcinoma 49 NOMID 49 chronic lymphocytic 49 MSH2 49 cytokine refractory 49 ALDH 49 histologic subtype 49 mesenchymal cell 49 actinic keratosis 49 osteopontin 49 BRAF mutations 49 lymphocyte 49 BRAF protein 49 Acute Myeloid Leukaemia AML 49 muscular dystrophy cystic fibrosis 49 SCCHN 49 Aplastic anemia 49 glucocorticoid receptors 49 Vorinostat 49 KRAS wild 49 chronic GVHD 49 severe sepsis 49 Soft tissue sarcomas 49 cells hESCs 49 sPLA2 49 MPS VI 49 subependymal giant cell 49 canakinumab 49 colon tumors 49 neural crest stem cells 49 TNF antagonist 49 tumoral 49 Papillary 49 EGFR HER2 49 Prostatitis 49 tumor subtypes 49 infection progressive multifocal 49 Cryopyrin Associated Periodic Syndromes 49 Peanut allergy 49 interferon alfa 49 INCB# [003] 49 cystic fibrosis CF 49 breast cancer subtypes 49 gastric adenocarcinoma 49 hormone refractory 49 lymphoma Hodgkin lymphoma 49 relapsed acute lymphoblastic 49 LY# [003] 49 Gorlin syndrome 49 inherited metabolic disorders 49 TNFalpha 49 Brentuximab Vedotin SGN 49 bacteraemia 49 pleural mesothelioma 49 PNET 49 Relapsed Refractory 49 Gleevec imatinib